Iseki K - Search Results

1

Nateglinide uptake by a ceftibuten transporter in the rat kidney brush-border membrane.

Kobayashi M, Saito Y, Itagaki S, Hirano T, Iseki K. Kobayashi M, et al. Among authors: iseki k. Biochim Biophys Acta. 2005 Aug 30;1715(1):19-24. doi: 10.1016/j.bbamem.2005.05.013. Biochim Biophys Acta. 2005. PMID: 16087153 Free article.

2

Ionic strength has a greater effect than does transmembrane electric potential difference on permeation of tryptamine and indoleacetic acid across Caco-2 cells.

Sugawara M, Kurosawa M, Sakai K, Kobayashi M, Iseki K, Miyazaki K. Sugawara M, et al. Among authors: iseki k. Biochim Biophys Acta. 2002 Aug 19;1564(1):149-55. doi: 10.1016/s0005-2736(02)00442-x. Biochim Biophys Acta. 2002. PMID: 12101007 Free article.

3

Major role of organic anion transporters in the uptake of phenolsulfonphthalein in the kidney.

Itagaki S, Sugawara M, Kobayashi M, Nishimura S, Fujimoto M, Miyazaki K, Iseki K. Itagaki S, et al. Among authors: iseki k. Eur J Pharmacol. 2003 Aug 15;475(1-3):85-92. doi: 10.1016/s0014-2999(03)02111-3. Eur J Pharmacol. 2003. PMID: 12954363

4

Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration.

Yagasaki K, Gando S, Matsuda N, Kameue T, Ishitani T, Hirano T, Iseki K. Yagasaki K, et al. Among authors: iseki k. Intensive Care Med. 2003 Oct;29(10):1844-8. doi: 10.1007/s00134-003-1980-z. Epub 2003 Sep 13. Intensive Care Med. 2003. PMID: 13680113

5

Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration.

Yagasaki K, Gando S, Matsuda N, Kameue T, Ishitani T, Hirano T, Iseki K. Yagasaki K, et al. Among authors: iseki k. Intensive Care Med. 2003 Nov;29(11):2094-5. doi: 10.1007/s00134-003-1914-9. Epub 2003 Sep 20. Intensive Care Med. 2003. PMID: 14504724 No abstract available.

6

Biliary excretion of irinotecan and its metabolites.

Itoh T, Takemoto I, Itagaki S, Sasaki K, Hirano T, Iseki K. Itoh T, et al. Among authors: iseki k. J Pharm Pharm Sci. 2004 Jan 23;7(1):13-8. J Pharm Pharm Sci. 2004. PMID: 15144730 Free article.

7

Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats.

Itoh T, Itagaki S, Sasaki K, Hirano T, Takemoto I, Iseki K. Itoh T, et al. Among authors: iseki k. J Pharm Pharmacol. 2004 Jun;56(6):809-12. doi: 10.1211/0022357023420. J Pharm Pharmacol. 2004. PMID: 15231047

8

H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine.

Itagaki S, Saito Y, Kubo S, Otsuka Y, Yamamoto Y, Kobayashi M, Hirano T, Iseki K. Itagaki S, et al. Among authors: iseki k. J Pharmacol Exp Ther. 2005 Jan;312(1):77-82. doi: 10.1124/jpet.104.074021. Epub 2004 Aug 17. J Pharmacol Exp Ther. 2005. PMID: 15316092

9

Comparison of urinary excretion of phenolsulfonphthalein in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Wistar rats: involvement of primary active organic anion transporter.

Itagaki S, Shimamoto S, Hirano T, Iseki K, Sugawara M, Nishimura S, Fujimoto M, Kobayashi M, Miyazaki K. Itagaki S, et al. Among authors: iseki k. J Pharm Pharm Sci. 2004 Jul 13;7(2):227-34. J Pharm Pharm Sci. 2004. PMID: 15367380 Free article.

10

Comparison of the disposition behavior of organic anions in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Long-Evans Agouti rats.

Itagaki S, Sugawara M, Kobayashi M, Miyazaki K, Hirano T, Iseki K. Itagaki S, et al. Among authors: iseki k. Drug Metab Pharmacokinet. 2004 Apr;19(2):150-4. doi: 10.2133/dmpk.19.150. Drug Metab Pharmacokinet. 2004. PMID: 15499181 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

877 results

Search Page

Filters